Publication | Closed Access
Genetic variants in the renin–angiotensin system predict response to bevacizumab in cancer patients
20
Citations
26
References
2015
Year
A higher activity of ACE-angiotensin-II-AGTR1 axis is associated with a better response to bevacizumab, supporting that the RAS can be an important source of potential predictive markers of response to anti-angiogenic drugs.
| Year | Citations | |
|---|---|---|
Page 1
Page 1